American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about PowerSchool’s (PWSC) Overweight Rating Reaffirmed at Piper Sandler

PowerSchool’s (PWSC) Overweight Rating Reaffirmed at Piper Sandler

Piper Sandler reiterated their overweight rating on shares of PowerSchool (NYSE:PWSC – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. The brokerage currently has a $29.00 target price on the... More of this article »
Image about Tenable’s (TENB) Buy Rating Reaffirmed at Needham & Company LLC

Tenable’s (TENB) Buy Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Tenable (NASDAQ:TENB – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. They currently have a $62.00 price target on the stock. Several... More of this article »
Image about Lexicon Pharmaceuticals’ (LXRX) “Hold” Rating Reaffirmed at Needham & Company LLC

Lexicon Pharmaceuticals’ (LXRX) “Hold” Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reissued their hold rating on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. Separately, StockNews.com upgraded shares... More of this article »
Image about Gold Royalty (NYSEAMERICAN:GROY) Given “Buy” Rating at HC Wainwright

Gold Royalty (NYSEAMERICAN:GROY) Given “Buy” Rating at HC Wainwright

HC Wainwright reissued their buy rating on shares of Gold Royalty (NYSEAMERICAN:GROY – Free Report) in a research note published on Tuesday morning, Benzinga reports. The firm currently has a $5.75 price target on the stock. Gold... More of this article »
Image about Legend Biotech (NASDAQ:LEGN) Receives “Buy” Rating from HC Wainwright

Legend Biotech (NASDAQ:LEGN) Receives “Buy” Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Legend Biotech (NASDAQ:LEGN – Free Report) in a report published on Tuesday, Benzinga reports. HC Wainwright currently has a $87.00 price target on the stock. LEGN has been... More of this article »
Image about MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives “Buy” Rating from HC Wainwright

MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives “Buy” Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in a report published on Tuesday, Benzinga reports. HC Wainwright currently has a $100.00 price target on the stock. MLTX... More of this article »
Image about Hilton Worldwide (NYSE:HLT) Price Target Lowered to $242.00 at Mizuho

Hilton Worldwide (NYSE:HLT) Price Target Lowered to $242.00 at Mizuho

Hilton Worldwide (NYSE:HLT – Free Report) had its price objective cut by Mizuho from $245.00 to $242.00 in a report released on Tuesday, Benzinga reports. They currently have a buy rating on the stock. HLT has been the subject... More of this article »
Image about Kinetik (NASDAQ:KNTK) Price Target Increased to $42.00 by Analysts at Mizuho

Kinetik (NASDAQ:KNTK) Price Target Increased to $42.00 by Analysts at Mizuho

Kinetik (NASDAQ:KNTK – Free Report) had its price target lifted by Mizuho from $39.00 to $42.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have a buy rating on the stock. A number of other... More of this article »
Image about Marriott International (NASDAQ:MAR) Price Target Cut to $260.00 by Analysts at Mizuho

Marriott International (NASDAQ:MAR) Price Target Cut to $260.00 by Analysts at Mizuho

Marriott International (NASDAQ:MAR – Free Report) had its price target cut by Mizuho from $263.00 to $260.00 in a report released on Tuesday, Benzinga reports. They currently have a neutral rating on the stock. Several other... More of this article »
Image about Hyatt Hotels (NYSE:H) Price Target Cut to $195.00 by Analysts at Mizuho

Hyatt Hotels (NYSE:H) Price Target Cut to $195.00 by Analysts at Mizuho

Hyatt Hotels (NYSE:H – Free Report) had its target price reduced by Mizuho from $197.00 to $195.00 in a report published on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. Several other equities... More of this article »
Image about Impinj (NASDAQ:PI) Price Target Increased to $140.00 by Analysts at Susquehanna

Impinj (NASDAQ:PI) Price Target Increased to $140.00 by Analysts at Susquehanna

Impinj (NASDAQ:PI – Free Report) had its price target lifted by Susquehanna from $130.00 to $140.00 in a report published on Tuesday, Benzinga reports. Susquehanna currently has a positive rating on the stock. Several other brokerages... More of this article »
Image about Chewy (NYSE:CHWY) Price Target Lowered to $16.00 at Piper Sandler

Chewy (NYSE:CHWY) Price Target Lowered to $16.00 at Piper Sandler

Chewy (NYSE:CHWY – Free Report) had its price target trimmed by Piper Sandler from $19.00 to $16.00 in a research report report published on Tuesday, Benzinga reports. The firm currently has a neutral rating on the stock. CHWY... More of this article »
Image about Intel (NASDAQ:INTC) Given New $37.00 Price Target at HSBC

Intel (NASDAQ:INTC) Given New $37.00 Price Target at HSBC

Intel (NASDAQ:INTC – Free Report) had its price target lowered by HSBC from $44.00 to $37.00 in a research report released on Tuesday, Benzinga reports. The firm currently has a hold rating on the chip maker’s stock. Several... More of this article »
Image about Northwest Bancshares (NASDAQ:NWBI) Given New $10.00 Price Target at Piper Sandler

Northwest Bancshares (NASDAQ:NWBI) Given New $10.00 Price Target at Piper Sandler

Northwest Bancshares (NASDAQ:NWBI – Free Report) had its price target reduced by Piper Sandler from $11.00 to $10.00 in a report published on Tuesday, Benzinga reports. Piper Sandler currently has an underweight rating on the... More of this article »
Image about Wolfspeed (NYSE:WOLF) Price Target Lowered to $25.00 at Susquehanna

Wolfspeed (NYSE:WOLF) Price Target Lowered to $25.00 at Susquehanna

Wolfspeed (NYSE:WOLF – Free Report) had its price objective reduced by Susquehanna from $35.00 to $25.00 in a research note published on Tuesday morning, Benzinga reports. Susquehanna currently has a neutral rating on the stock. Several... More of this article »